Algorithmiq, a quantum computing startup specializing in quantum algorithms for life sciences, successfully ran an extensive error mitigation experiment on IBM’s Nazca, the 127-qubit Eagle processor, utilizing 50 active qubits across 98 layers of CNOTS, totaling 2402 CNOTS gates.
According to Algorithmiq, quantum computers, despite their potential, face high error rates that limit large-scale computations. Overcoming these errors is crucial for meaningful quantum calculations.
“Algorithmiq’s proprietary error mitigation algorithms, showcased at IBM’s Quantum Summit, address this challenge, forming the backbone of their drug discovery platform, Aurora,” Algorithmiq said in a media release. “The successful demonstration highlighted scalable error mitigation, a critical step toward achieving quantum advantage in chemistry.”
IDC lowers forecast for quantum computing spend
IBM unveils its latest quantum computing processor
The startup’s achievement stems from employing Tensor Network Error Mitigation (TEM) techniques, a proprietary method developed in collaboration with IBM Zurich and Trinity College Dublin.
Large-scale experiments
“These techniques effectively tackled noise even in complex circuits, surpassing previous error mitigation methods and significantly reducing computation time from years to hours,” the company explained.
“Today represents further validation that Algorithmiq’s core error mitigation techniques are powerful and will enable large-scale experiments on specific use cases leading us well into the quantum utility era for real commercial applications,” said Prof. Sabrina Maniscalco, co-founder and CEO of Algorithmiq.
In a strategic move, Algorithmiq assumed ownership of Qiskit Nature code from IBM. This transition, announced by IBM in its latest blog, reflects Algorithmiq’s commitment to advancing quantum computing and fostering community-driven software development.
Algorithmiq secured a substantial investment of up to $4.25 million from Wellcome Leap. This funding will drive research into photon-drug interactions for cancer prevention and treatment, underscoring their commitment to innovative partnerships and groundbreaking research in life sciences.